We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Huntington's Disease

News List

NeuExcell Therapeutics and Spark Therapeutics Announce Research Collaboration Agreement to Develop a Novel Gene Therapy for Huntington's Disease prnasia
September 13, 2021
OTCQX: RHHBY) today announced a gene therapy collaboration aimed at developing a safe and effective treatment for patients suffering from Huntington's Disease (HD).
PTC Therapeutics Announces Trial for Huntington's Disease americanpharmaceuticalreview
December 01, 2020
PTC Therapeutics announced the initiation of a Phase 1 clinical trial to evaluate PTC518 in healthy volunteers. PTC518 was identified from PTC's splicing platform and is being developed for the treatment of Huntington's disease (HD).
A drug lowers Huntington’s disease protein for the first time biospectrumasia
December 18, 2017
This is the first time the protein known to cause Huntington’s has been lowered in the nervous system of patients.